The effectiveness of blood amount used in pleurodesis to prevent prolonged air leakage.

Air leakage blood pleurodesis pneumothorax

Journal

Turk gogus kalp damar cerrahisi dergisi
ISSN: 1301-5680
Titre abrégé: Turk Gogus Kalp Damar Cerrahisi Derg
Pays: Turkey
ID NLM: 100887967

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 26 08 2019
accepted: 11 11 2019
entrez: 17 3 2020
pubmed: 17 3 2020
medline: 17 3 2020
Statut: epublish

Résumé

This study aims to investigate the effects of different amounts of blood used in autologous blood patch pleurodesis on clinical outcomes in patients with secondary spontaneous pneumothorax. Between January 2015 and April 2019, a total of 42 patients (36 males, 6 females; mean age 52.1±16.0 years; range, 25 to 83 years) with SSP treated in our clinic with persistent air leakage for more than seven days were retrospectively analyzed. The patients were divided into two groups as receiving 60 mL autologous blood patch pleurodesis (Group 1, n=20) and 120 mL autologous blood patch pleurodesis (Group 2, n=22). Data including age, gender, operation side, complications, recurrence rates, time to tube withdrawal, and length of hospital stay were recorded and compared between the groups. The mean duration of air leakage was 3.3±2.4 (range, 1 to 11) days, the mean number of pleurodesis was 1.6±0.7 (range, 1 to 3), the mean time to tube withdrawal was 5.2±3.3 (range, 1 to 16) days, the mean length of hospitalization was 7.1±3.6 (range, 3 to 18) days. There were statistically significant differences in all variables analyzed between Group 1 and Group 2 (p<0.001). Autologous blood patch pleurodesis is an effective and safe method in the treatment of prolonged air leakage in secondary spontaneous pneumothorax. In addition, 120 mL of blood seems to be more effective option for pleurodesis.

Sections du résumé

BACKGROUND BACKGROUND
This study aims to investigate the effects of different amounts of blood used in autologous blood patch pleurodesis on clinical outcomes in patients with secondary spontaneous pneumothorax.
METHODS METHODS
Between January 2015 and April 2019, a total of 42 patients (36 males, 6 females; mean age 52.1±16.0 years; range, 25 to 83 years) with SSP treated in our clinic with persistent air leakage for more than seven days were retrospectively analyzed. The patients were divided into two groups as receiving 60 mL autologous blood patch pleurodesis (Group 1, n=20) and 120 mL autologous blood patch pleurodesis (Group 2, n=22). Data including age, gender, operation side, complications, recurrence rates, time to tube withdrawal, and length of hospital stay were recorded and compared between the groups.
RESULTS RESULTS
The mean duration of air leakage was 3.3±2.4 (range, 1 to 11) days, the mean number of pleurodesis was 1.6±0.7 (range, 1 to 3), the mean time to tube withdrawal was 5.2±3.3 (range, 1 to 16) days, the mean length of hospitalization was 7.1±3.6 (range, 3 to 18) days. There were statistically significant differences in all variables analyzed between Group 1 and Group 2 (p<0.001).
CONCLUSION CONCLUSIONS
Autologous blood patch pleurodesis is an effective and safe method in the treatment of prolonged air leakage in secondary spontaneous pneumothorax. In addition, 120 mL of blood seems to be more effective option for pleurodesis.

Identifiants

pubmed: 32175159
doi: 10.5606/tgkdc.dergisi.2020.18659
pmc: PMC7067004
doi:

Types de publication

Journal Article

Langues

eng

Pagination

175-180

Informations de copyright

Copyright © 2020, Turkish Society of Cardiovascular Surgery.

Déclaration de conflit d'intérêts

Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Références

Thorax. 2010 Aug;65 Suppl 2:ii18-31
pubmed: 20696690
Eur J Cardiothorac Surg. 2005 May;27(5):935
pubmed: 15848351
Scand Cardiovasc J. 1998;32(2):75-8
pubmed: 9636962
Lung India. 2018 Jul-Aug;35(4):328-331
pubmed: 29970773
Can J Surg. 1987 Nov;30(6):428-9
pubmed: 3664409
Eur J Cardiothorac Surg. 2004 Nov;26(5):897-900
pubmed: 15519179
Intern Med. 2011;50(11):1157-62
pubmed: 21628929
Thorax. 2005 Dec;60(12):1066-7
pubmed: 16299120
Interact Cardiovasc Thorac Surg. 2010 Oct;11(4):468-72
pubmed: 20628018
J Thorac Cardiovasc Surg. 2007 Mar;133(3):759-62
pubmed: 17320580
Ann Thorac Surg. 2001 Apr;71(4):1402-3
pubmed: 11308217
Ann Thorac Surg. 2000 Jul;70(1):270-2
pubmed: 10921721
Rev Clin Esp. 1997 Jun;197(6):406-10
pubmed: 9304131
J Thorac Cardiovasc Surg. 2006 Sep;132(3):556-9
pubmed: 16935110
Thorax. 2009 Mar;64(3):258-60
pubmed: 19252020
J Cardiothorac Surg. 2010 Aug 17;5:61
pubmed: 20716367
Curr Opin Pulm Med. 2012 Jul;18(4):333-8
pubmed: 22498731
J Pak Med Assoc. 2016 May;66(5):554-8
pubmed: 27183935

Auteurs

Erkan Akar (E)

Department of Thoracic Surgery, University of Health Sciences, Bursa Yüksek İhtisas Training and Research Hospital, Bursa, Turkey.

Miktat Arif Haberal (MA)

Department of Thoracic Surgery, University of Health Sciences, Bursa Yüksek İhtisas Training and Research Hospital, Bursa, Turkey.

Özlem Şengören Dikiş (Ö)

Department of Chest Diseases, University of Health Sciences, Bursa Yüksek İhtisas Training and Research Hospital, Bursa, Turkey.

Classifications MeSH